CIK 0001411690 · Non-accelerated filer<br>Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261756290
- Phone
- (858) 888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 25-NSE Other Notification of Removal from Listing
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market buy President and CEO bought 1,630 shares at $6.13 ($9,984)
- 4 Open-market buy Chief Operating Officer bought 815 shares at $6.13 ($4,992)
- 4 Conversion 10% owner acquired 2,906,915 shares (conversion)
- 4 Conversion Director acquired 2,906,915 shares (conversion)
- 4 Conversion Director acquired 2,906,915 shares (conversion)
- 4 Conversion Chief Scientific Officer acquired 111,523 shares (conversion)
- 4 Open-market buy Director bought 10,000 shares at $6.13 ($61,250)
- 3 Insider Initial Statement of Ownership
- 4 Conversion 10% owner acquired 6,891 shares (conversion)
- 4 Open-market buy 10% owner bought 15,000 shares at $6.13 ($91,875)
- 8-K Event Bylaws or fiscal year change
- CT ORDER Other Confidential Order
- 424B4 Offering Prospectus
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 29 of 32 · 633 filings